新冠肺炎高血压患者RAAS阻滞剂的使用-ESH/ISH/AHA声明解读

Chen Chen; Jianjun Mu

doi:10.7652/jdyxb202005030

新冠肺炎高血压患者RAAS阻滞剂的使用-ESH/ISH/AHA声明解读

Chen Chen
, Jianjun Mu

The First Affiliated Hospital of Xi’an Jiaotong University

科研成果: 期刊稿件 › 文献综述 › 同行评审

摘要

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.

投稿的翻译标题	Treatment of RAAS inhibitors for hypertensive patients in the coronavirus disease 2019 pandemic from ESH/ISH/AHA statements
源语言	繁体中文
页（从-至）	802-806
页数	5
期刊	Journal of Xi'an Jiaotong University (Medical Sciences)
卷	41
期	5
DOI	https://doi.org/10.7652/jdyxb202005030
出版状态	已出版 - 5 9月 2020
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

关键词

Coronavirus disease 2019(COVID-19)
Hypertension
RAAS inhibitor
SARS-CoV-2

访问文件

10.7652/jdyxb202005030

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{6c86a2b8740247cea81c09693010d83f,

title = "新冠肺炎高血压患者RAAS阻滞剂的使用-ESH/ISH/AHA声明解读",

abstract = "Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.",

keywords = "Coronavirus disease 2019(COVID-19), Hypertension, RAAS inhibitor, SARS-CoV-2",

author = "Chen Chen and Jianjun Mu",

year = "2020",

month = sep,

day = "5",

doi = "10.7652/jdyxb202005030",

language = "繁体中文",

volume = "41",

pages = "802--806",

journal = "Journal of Xi'an Jiaotong University (Medical Sciences)",

issn = "1671-8259",

publisher = "Xi'an Medical University",

number = "5",

}

TY - JOUR

T1 - 新冠肺炎高血压患者RAAS阻滞剂的使用-ESH/ISH/AHA声明解读

AU - Chen, Chen

AU - Mu, Jianjun

PY - 2020/9/5

Y1 - 2020/9/5

N2 - Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.

AB - Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is spreading all over the word. ACE2 is considered as the target receptor to invade humans. Hypertension is one of the most common non-communicable diseases. Many hypertensive patients are treated with RAAS inhibitors,whichare reported toincrease the expression of ACE2. Hence, whether hypertensive patients should continue the therapy of RAAS inhibitors has become the concern around the world. Considering the recent statements from several authoritative organizations, in this article, we make an in-depth discussion on the use of RAAS inhibitors for hypertensive patients.

KW - Coronavirus disease 2019(COVID-19)

KW - Hypertension

KW - RAAS inhibitor

KW - SARS-CoV-2

UR - https://www.scopus.com/pages/publications/85091036657

U2 - 10.7652/jdyxb202005030

DO - 10.7652/jdyxb202005030

M3 - 文献综述

AN - SCOPUS:85091036657

SN - 1671-8259

VL - 41

SP - 802

EP - 806

JO - Journal of Xi'an Jiaotong University (Medical Sciences)

JF - Journal of Xi'an Jiaotong University (Medical Sciences)

IS - 5

ER -

新冠肺炎高血压患者RAAS阻滞剂的使用-ESH/ISH/AHA声明解读

摘要

联合国可持续发展目标

关键词

访问文件

其它文件与链接

学术指纹

引用此